← FDA DRUG APPROVALS

FDA ANDA · ANDA084003

QUINIDINE SULFATE

Sponsor: PUREPAC PHARM

APPLICATION
ANDA084003
TYPE
ANDA
ORIGINAL APPROVAL
1976-10-06
LATEST ACTION
1998-02-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

QUINIDINE SULFATEDiscontinued
QUINIDINE SULFATE 200MG · TABLET · ORAL

Approval history

1998-02-20Labeling · Supplement 3AP
1990-06-01Labeling · Supplement 38AP
1988-11-29Labeling · Supplement 36AP
1976-10-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →